This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.Find sources: "WIN 56,098" – news · newspapers · books · scholar · JSTOR (April 2011) (Learn how and when to remove this message)
WIN 56,098
Identifiers
  • Anthracen-9-yl-{2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methanone
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC30H28N2O2
Molar mass448.566 g·mol−1
3D model (JSmol)
  • O=C(c3c1ccccc1cc2ccccc23)c4c6ccccc6n(c4C)CCN5CCOCC5

WIN 56,098 is a chemical that is considered to be an aminoalkylindole derivative. It is a tricyclic aryl derivative that acts as a competitive antagonist at the CB2 cannabinoid receptor. Its activity at CB1 was significantly less effective. WIN 56,098 failed to antagonize any of the in vivo effects of THC.[1]

See also

References

  1. ^ Howlett AC, Berglund B, Melvin LS (October 1995). "Cannabinoid Receptor Agonists and Antagonists". Current Pharmaceutical Design. 1 (3): 343–352. doi:10.2174/1381612801666220918164118. S2CID 252386978.


Categories